PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1408916
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1408916
Pharmaceutical Packaging Market size was valued at USD 139,973 Million in 2023, expanding at a CAGR of 9.5% from 2024 to 2032.
A pharmaceutical product's packaging is an essential component. Packaging frequently has an impact on how medicinal products are used, dosed, and dispensed. Labels warning of correct usage and other relevant information are also controlled. Pharmaceutical products come in a variety of package styles that fall into three categories: primary, secondary, and tertiary.
There is fierce competition for the packaging from other kinds of packaging. For commercial purposes, the pharmaceutical sector is also seeking glass material packaging. Pharma companies engage in pharmaceutical packaging for a variety of reasons, including loadability, breakages, and unit cost. To compete with other options, producers are creating sturdy, lightweight bottles for pharmaceuticals. It is imperative to design and manufacture suitable packaging for pharmaceutical goods to guarantee the safe transportation, storage, and dispensing of medications-some of which have the potential to save lives. The two materials most frequently used in pharmaceutical packaging are plastic and glass. Glass is usually favored because of the features that make it easy to clean and let us see what's within. The pharmaceutical business has depended on developing safe and secure packaging for a variety of medications for many years.
Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. North America is expected to dominate the market during the forecast period. There is a notable concentration of major pharmaceutical companies in the region from Mexico, the United States, and Canada. Due to its highly established healthcare system, substantial expenditures in drug discovery, and high per capita income, the United States is recognized as the world's largest pharmaceutical market. Furthermore, the region's growth is anticipated to be significantly aided by the presence of several top manufacturers of healthcare products, including Johnson & Johnson, Pfizer Inc., Bristol-Myers Squibb Company, Merck & Co., Inc., and AbbVie Inc.
The key players operating in the market are Schott AG, Berry Global, Inc., AptarGroup, Inc., Drug Plastics Group, Gerresheimer AG, Amcor plc, Owens Illinois, Inc., West Pharmaceutical Services, Inc., BD, WestRock Company, SGD Pharma, International Paper, Comar, LLC, CCL Industries, Inc. and Vetter Pharma International among others. These players adopted various types of strategies such as product launch, acquisition, collaboration and others to gain maximum market share.
In February 2023, with the launch of a completely certified tamper-evident (TE) and child-resistant (CRC) packaging solution designed for the pharmaceutical and herbal sector and especially for syrup and liquid medications, Berry Global Healthcare marked a noteworthy milestone. The extensive selection consists of seven series of 28mm neck PET bottles, with capacities ranging from 20ml to 1,000ml. The bottles provide a variety of design choices to meet the demands of different customers.
The scope of this report covers the market by its major segments, which include as follows: